Remdesivir-loaded bis-MPA hyperbranched dendritic nanocarriers for pulmonary delivery

Remdesivir is the only clinically available antiviral drug for the treatment of COVID-19. However, its very limited aqueous solubility confines its therapeutic activity and the development of novel inhaled nano-based drug delivery systems of remdesivir for enhanced lung tissue targeting and efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Halevas, Eleftherios, Mavroidi, Barbara, Kokotidou, Chrysoula, Moschona, Alexandra, Sagnou, Marina, Mitraki, Anna, Litsardakis, George, Pelecanou, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Opinion Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364662/
https://www.ncbi.nlm.nih.gov/pubmed/35966803
http://dx.doi.org/10.1016/j.jddst.2022.103625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364662/
https://www.ncbi.nlm.nih.gov/pubmed/35966803
http://dx.doi.org/10.1016/j.jddst.2022.103625

Ejemplares similares